跳至主要内容
临床试验/TCTR20240809002
TCTR20240809002尚未招募1 期

Evaluating Ribose Cross-linked Collagen Scaffold for Augmentation Buccal Contour at Dental-implant Sites: A Prospective Clinical Trial

C2F fund0 个研究点目标入组 30 人开始时间: 2024年8月9日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • a.Adult patients with good general health or well-controlled disease (ASA Class I or II)
  • b.Edentulous area at anterior or posterior region of maxilla or mandible
  • c.Single tooth edentulous space has facial bone thickness of at least 1 mm and needs contouring
  • d.Implant with bone level approach
  • e.1 stage implant surgical protocol.

排除标准

  • a.Patients who were unable to comply with the protocol requirements.
  • b.Patient has post-op dehiscence, infection.
  • c.Patients with a smoking habit (more than 10 cigarettes per day), alcoholism
  • d.Pregnant or lactating women
  • e.Patients who need adjacent implants.

研究者

发起方
C2F fund

相似试验

Evaluating Ribose Cross-linked Collagen Scaffold for... | 临床试验